SCHEMBL6167511

SCHEMBL6167511

NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2COCC(=O)O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.69
CA1 P00915 6/20 0.57
CA2 P00918 6/20 0.57
CA12 O43570 5/20 0.57
CA9 Q16790 5/20 0.57
PTGS1 P23219 3/20 0.57
CA4 P22748 2/20 0.57
CA7 P43166 2/20 0.57
MT-CO2 P00403 2/20 0.57
LMNA P02545 1/20 0.57
CA3 P07451 1/20 0.57
ADRB2 P07550 1/20 0.57
ADRB1 P08588 1/20 0.57
CYP3A4 P08684 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CHRM1 P11229 1/20 0.57
ADRA2B P18089 1/20 0.57
CA6 P23280 1/20 0.57
SLC6A2 P23975 1/20 0.57
PDE4A P27815 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8800869 0.90 PTGS2 (0.57) PTGS2CA1CA2CA12CA9
SCHEMBL8800861 0.89 PTGS2 (0.56) PTGS2CA1CA2CA12CA9
SCHEMBL4881634 0.85 PTGS2 (0.77) PTGS2CA1CA2CA12CA9
SCHEMBL4881595 0.84 PTGS2 (0.72) PTGS2CA1CA2CA12CA9
SCHEMBL4884126 0.83 PTGS2 (0.74) PTGS2CA1CA2CA12CA9
Hydroxylated Derivative SCHEMBL214649 0.82 PTGS2 (1.00) PTGS2CA1CA2CA12CA9
SCHEMBL3865943 0.82 PTGS2 (0.66) PTGS2CA1CA2CA12CA9
SCHEMBL3863782 0.82 PTGS2 (0.66) PTGS2CA1CA2CA12CA9
SCHEMBL8475019 0.82 PTGS2 (0.73) PTGS2CA1CA2CA12CA9
SCHEMBL3866517 0.81 PTGS2 (0.65) PTGS2CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP claimed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP claimed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP claimed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed